Azerbaijan

Reimbursed Care Access

Azerbaijan maintains a restrictive approach to classical psychedelics: most serotonergic and entheogenic compounds (psilocybin, MDMA, DMT, mescaline, etc.) are treated as controlled/illegal substances with no authorized medical use outside research or criminal prohibition. Ketamine is used and available in clinical settings (including state hospital formularies), but newer, branded psychedelic-derived medicines (e.g., esketamine/Spravato) do not appear in Azerbaijani regulatory or reimbursement lists. Enforcement actions against MDMA and other illicit stimulants are reported by national authorities, and the Criminal Code provides the legal framework for penalizing illicit trafficking and possession of controlled psychotropic substances. [https://en.apa.az/social/-141857|APA — Azerbaijan Health Ministry list] [https://en.wikipedia.org/wiki/Criminal_Code_of_Azerbaijan|Criminal Code of Azerbaijan] [https://www.trend.az/azerbaijan/society/2733362.html|Trend.az — State Security Service report].